A Phase 1 Trial Of MLN0128 (sapanisertib) And CB-839 HCl ... - NCBI

Từ khóa » Cb-839 Hcl

• Testing Of The Anti Cancer Drugs CB-839 HCl (Telaglenastat) And ...

• CB-839 HCl In Combination With Carfilzomib And Dexamethasone ...

• Phase 1 Trial Of MLN0128 (Sapanisertib) And CB-839 HCl ... - PubMed

• Phase 1 Trial Of MLN0128 (Sapanisertib) And CB-839 HCl ...

• Trial In Progress: Phase I Dose-Escalation And Dose-Expansion ...

• Phase 1 Trial Of MLN0128 (Sapanisertib) And CB-839 HCl ...

• A Phase I/II Study Of AZD9291 (Osimertinib) And CB-839 ...

• Testing Whether Cancers With Specific Mutations Respond Better To ...

• Telaglenastat (CB-839) - Glutaminase Inhibitor

• A Phase Ib Study Of AZD9291 (Osimertinib) And CB-839 HCl In ...

• A Study To Evaluate CB-839 HCl In Combination With Carfilzomib ...

• Safety And Tolerability Of Increasing Doses Of CB-839, A First-in-class ...

• Testing Of The Anti Cancer Drugs CB-839 HCl ... - CenterWatch